INS and cancer: miR-375, initially identified as a pancreatic islet-specific miRNA regulating insulin secretion, and findings highlight that miR-375 is significantly downregulated in various cancers and acts as a suppressor of key cancer hallmarks by targeting critical oncogene [51].